Targeting of interleukin-17 in the treatment of psoriasis
"Psoriasis" is a chronic immune-mediated inflammatory disorder with epidermal hyperplasia. There is some evidence that the cytokine interleukin-17A (often known as IL-17), which is mainly produced by Th17 cells, has a role in the pathogenesis of psoriasis. "IL-17" is a pro-inflam...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Revisão |
| Hizkuntza: | ingelesa |
| Argitaratua: |
2014
|
| Sarrera elektronikoa: | https://doi.org/10.2147/ccid.s67534 https://www.dovepress.com/getfile.php?fileID=21604 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|